A variant of the IGF-I gene is associated with blood pressure but not with left heart dimensions at the age of 2 years: The Generation R Study

European Journal of Endocrinology

Volumn 159, Issue 3, 2008, Pages 209-216

  van Houten, Vera A ^a   Mook Kanamori, Dennis O ^a   van Osch Gevers, Lennie ^b   Steegers, Eric A P ^a   Hofman, Albert ^a   Moll, Henriëtte A ^b   van Duijn, Cornelia M ^a   Helbing, Willem A ^b   Hokken Koelega, Anita C S ^b   Jaddoe, Vincent W V ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ALLELE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART SIZE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; BIRTH WEIGHT; CHILD DEVELOPMENT; COMPARATIVE STUDY; ETHNIC AND RACIAL GROUPS; FAMILY SIZE; GENETIC POLYMORPHISM; GENETICS; HEART VENTRICLE; HISTOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

BIRTH WEIGHT; BLOOD PRESSURE; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; FAMILY CHARACTERISTICS; FOLLOW-UP STUDIES; GENOTYPE; HEART VENTRICLES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; POLYMORPHISM, GENETIC; POPULATION GROUPS; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES;

EID: 53249115722     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0907     Document Type: Article

References (39)

1. Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Molecular Pathology 2001 54 311-316.
2. Laron Z. IGF-1 and insulin as growth hormones. Novartis Foundation Symposium 2004 262 56-77 (discussion 77-83, 265-268).
3. Accili D, Nakae J, Kim JJ, Park BC & Rother KI. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. Journal of Pediatric Endocrinology and Metabolism 1999 12 475-485.
4. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, Santeusanio F, Porcellati C & Brunetti P. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999 100 1802-1807.
5. Hunt KJ, Lukanova A, Rinaldi S, Lundin E, Norat T, Palmqvist R, Stattin P, Riboli E, Hallmans G & Kaaks R. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Annals of Epidemiology 2006 16 563-571.
6. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 106 939-944.
7. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120.
8. Sandhu MS, Heald AH, Gibson IM, Cruickshank JK, Dunger DB & Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745.
9. Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM & Lamberts SW. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. European J0ournal of Endocrinology 2003 148 171-175.
10. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Holman A, Lamberts SW, Oostra BA, Pols HA & van Duijn CM. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001 50 637-642.
11. Vaessen N, Janssen JA, Heutink P, Holman A, Lamberts SW, Oostra BA, Pols HA & van Duijn CM. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002 359 1036-1037.
12. Geelhoed JJ, Mook-Kanamori DO, Witteman JC, Hofman A, van Duijn CM, Moll HA, Steegers EA, Hokken-Koelega AC & Jaddoe VW. Variation in the IGF1 gene and growth in foetal life and infancy. The Generation R Study. Clinical Endocrinology 2008 68 382-389.
13. Bleumink GS, Schut AF, Sturkenboom MC, Janssen JA, Witteman JC, van Duijn CM, Hofman A & Stricker BH. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy. Heart 2005 91 239-240.
14. van Rijn MJ, Slooter AJ, Bos MJ, Catarino CF, Koudstaal PJ, Holman A, Breteler MM & van Duijn CM. Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. Journal of Neurology, Neurosurgery, and Psychiatry 2006 77 24-27.
15. Yazdanpanah M, Sayed-Tabatabaei FA, Janssen JA, Rietveld I, Holman A, Stijnen T, Pols HA, Lamberts SW, Witteman JC & van Duijn CM. IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes. European Journal of Endocrinology 2006 155 751-756.
16. Bleumink GS, Rietveld I, Janssen JA, van Rossum EF, Deckers JW, Holman A, Witteman JC, van Duijn CM & Stricker BH. Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study). American Journal of Cardiology 2004 94 384-386.
17. Rietveld I, Holman A, Pols RA, van Duijn CM, Lamberts SW & Janssen JA. An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance. European Journal of Endocrinology 2006 154 715-721.
18. Rietveld I, Ikram MK, Vingerling JR, Hofman A, Pols HA, Lamberts SW, de Jong PT, van Duijn CM & Janssen JA. An igf-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes 2006 55 2387-2391.
19. Yazdanpanah M, Rietveld I, Janssen JA, Njajou OT, Holman A, Stijnen T, Pols HA, Lamberts SW, Witteman JC & van Duijn CM. An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly Caucasian population. American Journal of Cardiology 2006 97 1274-1276.
20. Hofman A, Jaddoe VW, Mackenbach JP, Moll HA, Snijders RF, Steegers EA, Verhulst FC, Witteman JC & Buller HA. Growth, development and health from early fetal life until young adulthood: the Generation R Study. Paediatric and Perinatal Epidemiology 2004 18 61-72.
21. Jaddoe VW, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Verhulst FC, Witteman JC & Hofman A. The Generation R Study: design and cohort profile. European Journal of Epidemiology 2006 21 475-484.
22. Weber JL & May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. American Journal of Human Genetics 1989 44 388-396.
23. Allen NE, Davey GK, Key TJ, Zhang S & Narod SA. Serum insulin-like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene. Cancer Epidemiology, Biomarkers and Prevention 2002 11 319-320.
24. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD & Ben-Shlomo Y. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 2002 51 2313-2316.
25. Landmann E, Geller F, Schilling J, Rudloff S, Foeller-Gaudier E & Gartner L. Absence of the wild-type allele (192 base pairs) of a polymorphism in the promoter region of the IGF-I gene but not a polymorphism in the insulin gene variable number of tandem repeat locus is associated with accelerated weight gain in infancy. Pediatrics 2006 118 2374-2379.
26. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, van Duijn CM & Lamberts SW. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology 2004 61 195-203.
27. Bruce S & Alpert M. Adult/pediatric validation study of the CAS Model 740 non-invasive blood pressure monitor: AAMI SP10: 2002 Format, 2003.
28. Gomez-Marin O, Prineas RJ & Rastam L. Cuff bladder width and blood pressure measurement in children and adolescents. Journal of Hypertension 1992 10 1235-1241.
29. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH & Tayik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echocardiography 1989 2 358-367.
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I & Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology 1986 57 450-458.
31. Teichholz LE, Kreulen T, Herman MV & Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. American Journal of Cardiology 1976 37 7-11.
32. Reichek N & Devereux RB. Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. American Heart Journal 1982 103 202-203.
33. Gellermann J, Kraft S & Ehrich JH. Twenty-four-hour ambulatory blood pressure monitoring in young children. Pediatric Nephrology 1997 11 707-710.
34. Varda NM & Gregoric A. Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers. Pediatric Nephrology 2005 20 798-802.
35. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997 29 6901-699.
36. Argente J, Barrios V, Pozo J, Munoz MT, Hervas F, Stene M & Hernandez M. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. Journal of Clinical Endocrinology and Metabolism 1993 77 1522-1528.
37. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J & Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. Journal of Clinical Endocrinology and Metabolism 1995 80 2534-2542.
38. Pauliks LB, Cole KE & Mergner WJ. Increased insulin-like growth factor-1 protein in human left ventricular hypertrophy. Experimental and Molecular Pathology 1999 66 53-58.
39. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR & Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994 89 799-809.